Search

Your search keyword '"Pulmonary fibrosis -- Care and treatment -- Development and progression"' showing total 2 results
Start Over Descriptor "Pulmonary fibrosis -- Care and treatment -- Development and progression" Topic fibrogen inc.
2 results on '"Pulmonary fibrosis -- Care and treatment -- Development and progression"'

1. FibroGen Advances Phase 3 Clinical Development of Pamrevlumab for the Treatment of Idiopathic Pulmonary Fibrosis with Initiation of ZEPHYRUS-2

Subjects
FibroGen Inc., Medical research, Medicine, Experimental, Pulmonary fibrosis -- Care and treatment -- Development and progression, Biotechnology industry, Clinical trials, Business, international, Law
Abstract

(GlobeNewswire) - FibroGen, Inc.(NASDAQ: FGEN) today announced dosing of the first patient in the ZEPHYRUS-2 Phase 3 clinical study of pamrevlumab in patients with idiopathic pulmonary fibrosis (IPF), a chronic, [...]

Published
2020

2. FibroGen Advances Phase 3 Clinical Development of Pamrevlumab for the Treatment of Idiopathic Pulmonary Fibrosis with Initiation of ZEPHYRUS-2

Subjects
FibroGen Inc., Medical research, Medicine, Experimental, Pulmonary fibrosis -- Care and treatment -- Development and progression, Biotechnology industry, Clinical trials, Banking, finance and accounting industries, Business
Abstract

SAN FRANCISCO, Dec 22, 2020 (GLOBE NEWSWIRE via COMTEX) -- FibroGen, Inc. (NASDAQ: FGEN) today announced dosing of the first patient in the ZEPHYRUS-2 Phase 3 clinical study of pamrevlumab [...]

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results